A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2018-07-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 505
- Registration Number
- NCT00207688
A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2017-10-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Registration Number
- NCT00210665
Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-02-10
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 646
- Registration Number
- NCT00103506
© Copyright 2024. All Rights Reserved by MedPath